AlphaMol is an AI-based bio-pharmaceutical company focusing on G protein-coupled receptor drug discovery. The Cofounders of AlphaMol are leading scientists in the area of GPCRs. Many essential molecular mechanisms and biotechnology were invented by the members of AlphaMol.
What are the core strengths of your current team and what skills are you looking forward to integrate in the future?
(1) Accurate computational platform to predict GPCR structures which defeated Google's AlphaFold2 with more than 60% accuracy.
(2) Resolving membrane protein structure in real lipids
(3) Accurate platform for virtual screening
(4) biochips for GPCR biological testing in physiological condition